Safi R. Bahcall, President and CEO at SYNTA PHARMACEUTICALS CORP (SNTA), bought 20,000 shares at $3.75 ($75K) on 2013-11-13, disclosed to the SEC on 2013-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| SNTA | BUY | 2013-06-17 | $41K | — | Filing → |
| SNTA | BUY | 2013-06-06 | $40K | — | Filing → |
| SNTA | BUY | 2012-11-13 | $71K | — | Filing → |